There were no additional differences in the overall percentage distribution of NK, NK-like, CD4+ T, and CD8+ T lymphocytes between the control and COVID-19 groups or between COVID-19 ICU and non-ICU patients. The gene discussed is CD4; the disease is COVID-19.